Extreme caution on the use of sirolimus for the congenital hyperinsulinism in infancy patient
Abstract We have recently published on the limited effectiveness of sirolimus as a treatment option for hypoglycaemia as a consequence of hyperinsulinism. Our data oppose the view that mTOR inhibitors provide new opportunities for the treatment of patients with hyperinsulinism. We are not convinced...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMC
2017-04-01
|
| シリーズ: | Orphanet Journal of Rare Diseases |
| 主題: | |
| オンライン･アクセス: | http://link.springer.com/article/10.1186/s13023-017-0621-5 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|